Skip to main content
HCPCS Q9961 · Level II · Part B drug

Q9961: high osmolar contrast material (Conray), HCPCS Level II drug code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for Q9961

Billing unit
1 ML
Hocm 250-299mg/ml iodine,1ml
ASP payment limit
$0.205
October 2026; -8.5% vs July 2026
Practitioner MUE
200
MAI 3
OPPS status
SI N
NCCI exposure
2 col-2 pairs
100% allow a modifier
Coverage articles
0
none list this code

TL;DR

HCPCS Q9961 is the Level II code for High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml, billed per 1 ML. The Medicare Part B ASP payment limit for October 2026 is $0.205 per billing unit, down 8.5% from July 2026. The practitioner MUE allows up to 200 units per date of service (MAI 3), so a full 200-unit day is $41.00 at the current limit. Under OPPS it carries status indicator N. Diagnostic agents are usually packaged under OPPS (status N) in the hospital outpatient setting, so separate payment applies mainly in the physician office under Part B. Other HCPCS codes whose descriptor names high osmolar contrast material: Q9963 (the code whose CMS descriptor names no specific product); Q9958 (the code whose CMS descriptor names no specific product). The ASP crosswalk maps 1 NDC to it, sold as Conray by Liebel-Flarsheim Company LLC. It is the bundled column-2 code in 2 NCCI pairs, most often with Q9962, Q9963. No current Billing and Coding Article lists Q9961, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for Q9961 at $0.205 per 1 ML for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.224 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for Q9961
QuarterPayment limitPerCoinsurance
October 2026$0.2051 ML20%
July 2026$0.2241 ML—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to Q9961. Report the NDC in the claim's drug segment and bill the number of Q9961 units that equals the quantity administered divided by 1 ML; the last column gives units per full package.

NDCs that crosswalk to Q9961
NDCDrug nameLabelerPackage sizeBilling units / package
00019-0953-05ConrayLiebel-Flarsheim Company LLC50 × 251250

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for Q9961. For practitioners the limit is 200 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for Q9961 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services2003 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital2003 Date of Service Edit: ClinicalPrescribing Information

MUE for Q9961 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

In the practitioner PTP file v323r0 (effective October 1, 2026), Q9961 is the column-2 code in 2 active pairs, 100% of which allow a modifier (indicator 1), and the column-1 code in 8. 0 historical pairs have been deleted over time. CMS's most frequent rationale: Mutually exclusive procedures.

When billed with these column-1 codes, Q9961 is the bundled component unless the pair allows a modifier and the documentation supports a distinct service.

Column-1 codes most often paired with Q9961
Column-1 codePairs
Q9962 Hocm 300-349mg/ml iodine,1ml1
Q9963 Hocm 350-399mg/ml iodine,1ml1

These codes are considered components of Q9961 when reported together on the same date of service.

Column-2 codes most often bundled into Q9961
Column-2 codePairs
Q9951 Locm >= 400 mg/ml iodine,1ml1
Q9958 Hocm <=149 mg/ml iodine, 1ml1
Q9959 Hocm 150-199mg/ml iodine,1ml1
Q9960 Hocm 200-249mg/ml iodine,1ml1
Q9964 Hocm>= 400mg/ml iodine, 1ml1
Q9965 Locm 100-199mg/ml iodine,1ml1
Q9966 Locm 200-299mg/ml iodine,1ml1
Q9967 Locm 300-399mg/ml iodine,1ml1

The counts above are exposure, not answers for a specific claim. Check Q9961 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

Q9961 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists Q9961 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, Q9961 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), Q9961 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for Q9961 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for Q9961

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS Q9961

What does HCPCS code Q9961 describe?

Q9961 is defined by CMS as "High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml". Each billing unit represents 1 ML, so the units reported on the claim must equal the dose administered divided by that unit.

Is Q9961 a CPT code?

No. Q9961 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as high osmolar contrast material (Conray); CPT codes are five-character codes maintained by the AMA. On a Part B claim Q9961 reports the drug itself in 1 ml units, and the administration is billed on its own line.

What is the Medicare reimbursement for Q9961 in October 2026?

The ASP-based payment limit is $0.205 per 1 ML, with 20% beneficiary coinsurance. The July 2026 limit was $0.224. Commercial payers use their own fee schedules.

How many units of Q9961 can be billed per day?

The practitioner Medically Unlikely Edit is 200 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to Q9961?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Conray (Liebel-Flarsheim Company LLC). For example NDC 00019-0953-05 (package size 50) equals 1,250 billing units of Q9961.

Does Q9961 have NCCI bundling edits?

In the v323r0 practitioner PTP file, Q9961 appears as the column-2 (bundled) code in 2 active pairs and as the column-1 code in 8. 100% of the column-2 pairs allow a modifier (indicator 1). The most frequent column-1 partners are Q9962, Q9963, and CMS's leading rationale is "Mutually exclusive procedures".

Q9961 vs Q9963: what is the difference?

Both are HCPCS Level II codes whose descriptor names high osmolar contrast material. What sets Q9963 apart: the code whose CMS descriptor names no specific product. Q9961 is billed per 1 ml, limit $0.205, MUE 200; Q9963 is billed per 1 ml, limit $0.219, MUE 240. Report the code whose descriptor matches the product and setting in the record.

Q9961 vs Q9958: what is the difference?

Both are HCPCS Level II codes whose descriptor names high osmolar contrast material. What sets Q9958 apart: the code whose CMS descriptor names no specific product. Q9961 is billed per 1 ml, limit $0.205, MUE 200; Q9958 is billed per 1 ml, limit $0.08, MUE 300. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.